MENU
+Compare
SVRA
Stock ticker: NASDAQ
AS OF
Apr 1 closing price
Price
$2.86
Change
+$0.09 (+3.25%)
Capitalization
493.73M

SVRA Savara Forecast, Technical & Fundamental Analysis

Savara Inc is a biopharmaceutical company... Show more

Industry: #Biotechnology
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I.Advisor
a Summary for SVRA with price predictions
Mar 31, 2025

SVRA in upward trend: price rose above 50-day moving average on March 27, 2025

SVRA moved above its 50-day moving average on March 27, 2025 date and that indicates a change from a downward trend to an upward trend. In of 43 similar past instances, the stock price increased further within the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SVRA's RSI Oscillator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SVRA just turned positive on March 07, 2025. Looking at past instances where SVRA's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

The 10-day moving average for SVRA crossed bullishly above the 50-day moving average on March 21, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where SVRA advanced for three days, in of 243 cases, the price rose further within the following month. The odds of a continued upward trend are .

SVRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In of 59 cases where SVRA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are .

The Momentum Indicator moved below the 0 level on March 31, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on SVRA as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SVRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for SVRA entered a downward trend on February 28, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SVRA’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.879) is normal, around the industry mean (13.677). P/E Ratio (0.000) is within average values for comparable stocks, (64.969). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.870). Dividend Yield (0.000) settles around the average of (0.024) among similar stocks. P/S Ratio (0.000) is also within normal values, averaging (255.565).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SVRA’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock better than average.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

View a ticker or compare two or three
SVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Ad is loading...
A.I. Advisor
published Earnings

SVRA is expected to report earnings to fall 20.00% to -10 cents per share on May 08

Savara SVRA Stock Earnings Reports
Q1'25
Est.
$-0.10
Q4'24
Missed
by $0.02
Q3'24
Est.
$-0.11
Q2'24
Missed
by $0.02
Q1'24
Est.
$-0.11
The last earnings report on March 27 showed earnings per share of -12 cents, missing the estimate of -10 cents. With 1.09M shares outstanding, the current market capitalization sits at 493.73M.
A.I. Advisor
published General Information

General Information

a pharmaceuticals developer

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
1717 Langhorne Newtown Road
Phone
+1 512 614-1848
Employees
37
Web
https://www.savarapharma.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
WASAX21.46N/A
N/A
Macquarie Asset Strategy Fund Cl A
GIRGX21.03N/A
N/A
Goldman Sachs U.S. Equity ESG Inv
EISDX24.19N/A
N/A
Carillon ClariVest Intl Stock C
AATSX18.17N/A
N/A
Ancora/Thelen Small-Mid Cap S
HSWFX18.94N/A
N/A
Hartford Schroders International Stk F

SVRA and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, SVRA has been loosely correlated with LRMR. These tickers have moved in lockstep 47% of the time. This A.I.-generated data suggests there is some statistical probability that if SVRA jumps, then LRMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SVRA
1D Price
Change %
SVRA100%
-4.81%
LRMR - SVRA
47%
Loosely correlated
-8.51%
SLNO - SVRA
40%
Loosely correlated
-0.75%
ATXS - SVRA
39%
Loosely correlated
-6.32%
CCCC - SVRA
39%
Loosely correlated
-8.57%
KYMR - SVRA
38%
Loosely correlated
-7.60%
More